ARIZ Precision Medicine Press Releases

• Published on November 21, 2024 - 09:00 GMT

  ARIZ and NATA Announce Collaboration to develop multiple targeted nucleic acid therapies for cancer treatment

  DAVIS, CA, UNITED STATES, November 21, 2024 /⁨EINPresswire.com⁩/ -- The pioneering precision medicine company, ARIZ Precision Medicine (ARIZ), and the Medical Research Council’s Nucleic Acid Therapy Accelerator (NATA), today announced a collaboration to …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on August 20, 2024 - 18:00 GMT

  ARIZ Precision Medicine Announces Grant of Key US Patent Covering Lead Cancer Drug

  Novel siRNA in Development for Lung, Colon, Ovarian and Liver Cancers DAVIS, CALIFORNIA, UNITED STATES, August 20, 2024 /⁨EINPresswire.com⁩/ -- ARIZ Precision Medicine, Inc., a preclinical stage biopharmaceutical company developing precision ligand …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on June 24, 2022 - 18:55 GMT

  ARIZ Precision Medicine adds H. Michael Shepard, PhD to the company’s scientific advisory board

  ARIZ, The PRDM Oncogene Targeting Company™ to present new data on ARIZ-047 currently in advanced preclinical development for lung and other solid tumors. DAVIS, CALIFORNIA, UNITED STATES, June 24, 2022 /⁨EINPresswire.com⁩/ -- ARIZ Precision Medicine, a …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...